• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Aquatech Acquires Koch's Direct Lithium Extraction Business, Integrating Li-Pro™ DLE into the PEARL™ Technology Platform

    9/16/25 5:21:00 PM ET
    $A
    $EQNR
    $SLI
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Integrated oil Companies
    Energy
    Get the next $A alert in real time by email

    CANONSBURG, Pa., Sept. 16, 2025 /PRNewswire/ -- Aquatech has acquired Koch Technology Solutions' (KTS) direct lithium extraction (DLE) business, integrating the Li-Pro™ Lithium Selective Sorption (LSS) technology and extensive Li-Pro IP portfolio into the PEARL™ process technology platform.

    Aquatech and Koch logos

    The acquisition of KTS' Li-Pro LSS technology adds direct lithium extraction to Aquatech's extensive process flowsheet IP, lithium conversion and crystallization capabilities. With this addition, Aquatech's PEARL platform becomes the only commercially proven, end-to-end flowsheet solution for lithium processing. Spanning lithium extraction, purification and refining, the PEARL process technology platform delivers high-purity battery materials for electric vehicles (EV) and utility-scale electricity storage systems (ESS).

    The integration and optimization of upstream and downstream lithium processing will empower lithium resource owners with modularized process solutions at scale. This approach improves project bankability by removing process risk, accelerating project schedules and reducing the total cost of lithium production. Li-Pro LSS will be available under technology license as part of the PEARL full flowsheet licensing offerings.

    As part of the acquisition, all ongoing lithium extraction projects utilizing Li-Pro technology and associated licenses, agreements and performance guarantees will be transferred to Aquatech. This includes KTS' role in the Joint Development Agreement (JDA) with Standard Lithium Ltd. (TSXV:SLI) (NYSE:A) in the Smackover Formation, where they have completed over 12,000 operational cycles using Li-Pro technology at their demonstration plant and achieved an average lithium recovery of over 95%. It also includes a licensing agreement with Smackover Lithium, a joint venture between Standard Lithium and Equinor (NYSE:EQNR) (OSE:EQNR), for the first phase of its South West Arkansas project. The project is among the largest lithium projects in the US, with an initial phase of 22,500 tons per annum (tpa) of lithium carbonate equivalent targeting first production in 2028, with significant scope for future expansion.

    "Koch Technology Solutions has proven the Li-Pro LSS technology as a successful DLE solution, and the time has come to scale it for the market. Aquatech is uniquely placed to scale this technology and deliver it into projects as a cost competitive, end-to-end process solution, creating significant value for the lithium industry," commented Dave Dotson, President at Koch Engineered Solutions, the parent company of KTS.

    "We are confident that our legacy lithium customers will benefit from the broader offering of Aquatech. More broadly, Koch continues to maintain an active interest in the success of the technology via its investments in several key companies within the lithium minerals and lithium battery industries," said Garrett Krall, Critical Minerals & Lithium Business Leader at Koch Technology Solutions. 

     "Fragmented technology offerings increase project cost, risk and time-to-market, which has hindered the ramp-up of urgently needed critical minerals production in the Americas and Europe. Bringing Li-Pro into the PEARL technology platform solves this pressing industry need by offering the only proven full flowsheet solution that encompasses both upstream and downstream lithium processing technology," commented Venkee Sharma, Executive Chairman at Aquatech.

    Mr. Sharma continued, "We welcome the KTS Li-Pro team to Aquatech and commend them on the pioneering work done to develop Li-Pro LSS. With over 45 years of experience scaling commercially proven technologies, we are excited to evolve Li-Pro LSS both as a standalone technology offering and as part of the PEARL platform."

    About Aquatech

    Aquatech leverages innovative technology, engineering and execution leadership to solve the world's most demanding process challenges in lithium, critical minerals and industrial water. Aquatech's technology portfolio, project execution and service capabilities are grounded in a culture of performance excellence built up over four decades, with thousands of facilities using our solutions in over 60 countries.

    www.aquatech.com

    About Koch Technology Solutions

    Koch Technology Solutions (KTS) is a leader in technology licensing, delivering operating efficiency and capital productivity for licensees deploying the technologies in our portfolio. KTS partners with companies developing chemical process technologies to create attractive licensing solutions for commercial deployment, helping to bring the next generation of process technologies to the market.

    www.kochtechsolutions.com

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/aquatech-acquires-kochs-direct-lithium-extraction-business-integrating-li-pro-dle-into-the-pearl-technology-platform-302558347.html

    SOURCE Aquatech

    Get the next $A alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $A
    $EQNR
    $SLI

    CompanyDatePrice TargetRatingAnalyst
    Equinor ASA
    $EQNR
    3/24/2026$40.40Underweight → Equal-Weight
    Morgan Stanley
    Equinor ASA
    $EQNR
    3/20/2026Sell → Neutral
    UBS
    Equinor ASA
    $EQNR
    2/5/2026$22.00 → $25.00Hold
    TD Cowen
    Equinor ASA
    $EQNR
    2/5/2026Buy → Neutral
    BofA Securities
    Agilent Technologies Inc.
    $A
    1/20/2026$180.00Buy
    HSBC Securities
    Equinor ASA
    $EQNR
    1/8/2026Hold
    Jefferies
    Agilent Technologies Inc.
    $A
    1/5/2026$160.00In-line → Outperform
    Evercore ISI
    Agilent Technologies Inc.
    $A
    12/15/2025$165.00Equal Weight → Overweight
    Barclays
    More analyst ratings

    $A
    $EQNR
    $SLI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Henson Meghan

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    4/2/26 4:06:44 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 4 filed by Rataj Sue H.

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    3/23/26 4:39:21 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 4 filed by Brawley Otis W

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    3/23/26 4:36:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $A
    $EQNR
    $SLI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Gonsalves Rodney (Amendment)

    4/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    10/20/23 1:07:25 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Gonsalves Rodney bought $288 worth of shares (3 units at $111.09), increasing direct ownership by 0.01% to 24,222 units (SEC Form 4)

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    9/29/23 4:03:46 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $A
    $EQNR
    $SLI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Equinor upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Equinor from Underweight to Equal-Weight and set a new price target of $40.40

    3/24/26 1:44:44 PM ET
    $EQNR
    Integrated oil Companies
    Energy

    Equinor upgraded by UBS

    UBS upgraded Equinor from Sell to Neutral

    3/20/26 8:28:40 AM ET
    $EQNR
    Integrated oil Companies
    Energy

    TD Cowen reiterated coverage on Equinor with a new price target

    TD Cowen reiterated coverage of Equinor with a rating of Hold and set a new price target of $25.00 from $22.00 previously

    2/5/26 7:02:53 AM ET
    $EQNR
    Integrated oil Companies
    Energy

    $A
    $EQNR
    $SLI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Agilent Showcases Cancer Research Solutions at AACR 2026

    Agilent Technologies Inc. (NYSE:A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting on April 17–22, 2026, in San Diego, California. At the meeting, Agilent will highlight advances designed to connect discovery research, translational science, and companion diagnostics development, reflecting the growing demand for more integrated approaches across the cancer research continuum. Among the technologies featured is the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation series of cell imaging and multimode micropla

    4/15/26 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Oklo Announces Changes to its Board of Directors and Management Team to Support its Continued Growth

    Oklo welcomes Dr. Mark Peters, David Christian, Derek Kan, and David Park as new directors, bringing decades of experience executing complex and highly technical projects across a range of industries Oklo appoints Michael Thompson as Lead Independent Director Oklo announces plan to transition Pat Schweiger from Chief Technology Officer to a senior technical advisor Oklo Inc. (NYSE:OKLO), an advanced nuclear technology company, today announced changes to its Board of Directors and management team designed to enable Oklo to meet its ambitious deployment goals across its integrated power-fuel-isotopes business. "Over the past two years, we have built distinct business units respons

    4/14/26 4:15:00 PM ET
    $GL
    $OKLO
    $SLI
    Life Insurance
    Finance
    Electric Utilities: Central
    Utilities

    Equinor ASA: Proposal on capital reduction from the company's board of directors

    The board of directors of Equinor ASA ((OSE: EQNR, NYSE:EQNR) has today decided to propose to the general meeting of the company that the company's share capital is reduced through cancellation of own shares and redemption of shares belonging to the Norwegian State. The proposal is made as a result of the company having acquired own shares pursuant to the authorization for share buy-back granted by the annual general meeting of the company in May 2025. The proposal entails that the company's share capital shall be reduced by NOK 415,146,180.00 from NOK 6,392,018,780.00 to NOK 5,976,872,600.00 through cancellation and redemption of a total of 166,058,472 shares. Notice of the general meeting

    4/13/26 8:55:39 AM ET
    $EQNR
    Integrated oil Companies
    Energy

    $A
    $EQNR
    $SLI
    SEC Filings

    View All

    SEC Form 6-K filed by Equinor ASA

    6-K - EQUINOR ASA (0001140625) (Filer)

    4/13/26 9:23:13 AM ET
    $EQNR
    Integrated oil Companies
    Energy

    SEC Form 6-K filed by Standard Lithium Ltd.

    6-K - STANDARD LITHIUM LTD. (0001537137) (Filer)

    4/10/26 5:12:59 PM ET
    $SLI
    Major Chemicals
    Industrials

    Amendment: Agilent Technologies Inc. filed SEC Form 8-K: Changes in Control of Registrant, Leadership Update, Financial Statements and Exhibits

    8-K/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Filer)

    4/3/26 9:30:08 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $A
    $EQNR
    $SLI
    Leadership Updates

    Live Leadership Updates

    View All

    Agilent Showcases Cancer Research Solutions at AACR 2026

    Agilent Technologies Inc. (NYSE:A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting on April 17–22, 2026, in San Diego, California. At the meeting, Agilent will highlight advances designed to connect discovery research, translational science, and companion diagnostics development, reflecting the growing demand for more integrated approaches across the cancer research continuum. Among the technologies featured is the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation series of cell imaging and multimode micropla

    4/15/26 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Oklo Announces Changes to its Board of Directors and Management Team to Support its Continued Growth

    Oklo welcomes Dr. Mark Peters, David Christian, Derek Kan, and David Park as new directors, bringing decades of experience executing complex and highly technical projects across a range of industries Oklo appoints Michael Thompson as Lead Independent Director Oklo announces plan to transition Pat Schweiger from Chief Technology Officer to a senior technical advisor Oklo Inc. (NYSE:OKLO), an advanced nuclear technology company, today announced changes to its Board of Directors and management team designed to enable Oklo to meet its ambitious deployment goals across its integrated power-fuel-isotopes business. "Over the past two years, we have built distinct business units respons

    4/14/26 4:15:00 PM ET
    $GL
    $OKLO
    $SLI
    Life Insurance
    Finance
    Electric Utilities: Central
    Utilities

    Global Energy Pressures Elevate the Importance of New Supply Frontiers

    NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- NetworkNewsWire Editorial Coverage: Escalating geopolitical tensions and renewed disruptions to key shipping corridors, particularly around the Strait of Hormuz, are once again highlighting a persistent vulnerability: global energy security remains fragile. Despite years of diversification efforts, both the United States and Europe continue to face exposure to supply disruptions capable of cascading through economies, industries and households. In this environment, companies focused on unlocking new energy resources in politically stable regions are attracting increased attention. Greenland Energy Company (NASDAQ:GLND) (profile) is one such oper

    4/10/26 8:30:00 AM ET
    $CVX
    $E
    $EQNR
    Integrated oil Companies
    Energy
    Oil & Gas Production

    $A
    $EQNR
    $SLI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Agilent Technologies Inc.

    SC 13G/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/12/24 1:27:37 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Agilent Technologies Inc.

    SC 13G - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/12/24 11:54:03 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Agilent Technologies Inc.

    SC 13G - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/4/24 10:57:57 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $A
    $EQNR
    $SLI
    Financials

    Live finance-specific insights

    View All

    Scaling Lithium Operations to Meet Surging Global Demand

    NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Lithium mining is basically riding the same wave as electric vehicles and battery storage, and that wave is getting bigger every year. Demand has been climbing fast because lithium is a core ingredient in rechargeable batteries used in EVs, smartphones, and renewable energy systems. On the supply side, new mines take years to get up and running, so there's often a lag that keeps prices elevated. For investors, that imbalance—strong demand and slower supply growth—is a big part of what's making lithium such an attractive space right now as these Active Companies are looking for opportunities: US Critical Meta

    4/9/26 8:45:00 AM ET
    $ALB
    $LAC
    $SLI
    Major Chemicals
    Industrials
    Metal Mining
    Basic Materials

    Smackover Lithium Signs First Binding Customer Offtake Agreement for the South West Arkansas Project

    All figures are in US dollars unless otherwise stated. LEWISVILLE, Ark., March 09, 2026 (GLOBE NEWSWIRE) -- Smackover Lithium, a joint venture ("JV") between Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSXV:SLI) (NYSE.A: SLI) and Equinor, through subsidiaries of Equinor ASA, announced the signing of its first commercial offtake agreement for the South West Arkansas Project ("SWA Project" or the "Project") with Trafigura Trading LLC ("Trafigura"). Trafigura is a market leader in the global commodities industry, with an established presence across battery metals markets including lithium. Under the terms of this binding take-or-pay offtake agreement (the "Agreement"), the

    3/9/26 3:00:00 AM ET
    $SLI
    Major Chemicals
    Industrials

    Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

    Delivers solid Q1 results, raises FY26 reported revenue outlook and increases non-GAAP EPS(3) guidance while confirming core-revenue growth(1) and margin expansion First-quarter fiscal year 2026 Revenue of $1.80 billion for the first quarter ended Jan. 31, 2026, representing growth of 7.0% reported and up 4.4% on a core(1) basis compared with the first quarter of 2025. GAAP net income of $305 million; earnings per share (EPS) of $1.07, a decline of 4% from the first quarter of 2025. Non-GAAP(2) net income of $386 million; non-GAAP EPS(3) of $1.36, growing 4% from the first quarter of 2025. Fiscal year 2026 and second-quarter outlook Fiscal year 2026 revenue is expected in t

    2/25/26 4:05:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials